Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nikoo Chemical is a prominent Iranian pharmaceutical company focused on the manufacturing of Active Pharmaceutical Ingredients (APIs) and chemical intermediates. Established as a subsidiary of the Tamin Pharmaceutical Investment Company (TPICO), it serves as a critical supplier for the Iranian domestic drug market and regional partners. The company's manufacturing capabilities include the synthesis of widely used medications such as analgesics, cardiovascular agents, and anti-diabetic treatments. Nikoo Chemical operates under international quality standards, including Good Manufacturing Practice (GMP), to produce high-purity chemical components. Its strategic role involves reducing dependency on imported raw materials while expanding its footprint in the Middle Eastern pharmaceutical landscape. The company is recognized as one of the largest producers of bulk pharmaceutical chemicals in the region, particularly for essential medicines like acetaminophen and aspirin.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NIKOO Chemical.